Internal Medicine, Endocrinology, Diabetes, & Metabolism · Las Vegas, NV
NPI
1720031255
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
4475 S Eastern Ave
Las Vegas, NV, 89119
Phone (702) 877-5299
Groups this clinician bills Medicare through
Medicare paid, 2024
$8,057
103 services
Medicare patients, 2024
60
Average age 69
Drug cost, 2024
$1.3M
4,630 prescriptions
Company payments, 2025
$762
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sabita Moktan Sheikhai was code 99214 (office e&m - established), 81 times for 52 patients. In total Sabita Moktan Sheikhai billed 103 services in 6 codes, and Medicare paid $8,057.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-01-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 81 | 52 | $81.29 | $6,584 |
By year: 2022 $8,784 for 98 services; 2023 $8,268 for 103 services; 2024 $8,057 for 103 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sabita Moktan Sheikhai prescribed most often to Medicare patients was Levothyroxine Sodium, with 809 prescriptions and refills. In total Sabita Moktan Sheikhai wrote 4,630 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 809 | 2,343 | 232 | $6,230 |
| Methimazole Generic | 297 | 676 | 79 | $1,976 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 244 | 500 | 74 | $37K |
| Atorvastatin Calcium Generic | 189 | 555 | 66 | $1,613 |
| Humalog Kwikpen U-100 Insulin Lispro | 187 | 317 | 59 | $44K |
| Metformin Hcl Generic | 136 | 394 | 51 | $1,406 |
| Mounjaro Tirzepatide | 115 | 131 | 21 | $144K |
| Soliqua 100-33 Insulin Glargine/Lixisenatide | 106 | 211 | 31 | $167K |
| Glimepiride Generic | 104 | 298 | 40 | $1,160 |
| Metformin Hcl Er Metformin Hcl | 101 | 270 | 34 | $1,052 |
| Losartan Potassium Generic | 101 | 277 | 32 | $758 |
| Ozempic Semaglutide | 97 | 138 | 24 | $136K |
| Insulin Lispro Kwikpen U-100 Insulin Lispro | 92 | 143 | 31 | $20K |
| Jardiance Empagliflozin | 91 | 205 | 27 | $122K |
| Alendronate Sodium Generic | 84 | 214 | 29 | $636 |
Brand drugs: 1,953 claims; generic drugs: 2,513 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sabita Moktan Sheikhai $762 ($762 in general payments such as food, travel and fees) from 4 companies. The largest payer was Insulet Corporation with $261.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.